Iwata H - Search Results

1

Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women.

Hirose K, Toyama T, Iwata H, Takezaki T, Hamajima N, Tajima K. Hirose K, et al. Among authors: iwata h. Asian Pac J Cancer Prev. 2003 Jul-Sep;4(3):239-46. Asian Pac J Cancer Prev. 2003. PMID: 14507245 Free article.

2

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.

Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T, Hatooka S, Mitsudomi T, Suyama M, Kagami Y, Ogura M, Ando M, Sugimura Y, Tajima K. Hamajima N, et al. Among authors: iwata h. Int J Clin Oncol. 2002 Apr;7(2):103-8. doi: 10.1007/s101470200013. Int J Clin Oncol. 2002. PMID: 12018106

3

A49T, V89L and TA repeat polymorphisms of steroid 5alpha-reductase type II and breast cancer risk in Japanese women.

Yang C, Hamajima N, Iwata H, Saito T, Matsuo K, Hirose K, Inoue M, Takezaki T, Tajima K. Yang C, et al. Among authors: iwata h. Breast Cancer Res. 2002;4(4):R8. doi: 10.1186/bcr445. Epub 2002 Apr 25. Breast Cancer Res. 2002. PMID: 12100746 Free PMC article.

4

Significant reduction in breast cancer risk for Japanese women with interleukin 1B -31 CT/TT relative to CC genotype.

Ito LS, Iwata H, Hamajima N, Saito T, Matsuo K, Mizutani M, Iwase T, Miura S, Okuma K, Inoue M, Hirose K, Tajima K. Ito LS, et al. Among authors: iwata h. Jpn J Clin Oncol. 2002 Oct;32(10):398-402. doi: 10.1093/jjco/hyf081. Jpn J Clin Oncol. 2002. PMID: 12451035

5

Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.

Hishida A, Hamajima N, Iwata H, Matsuo K, Hirose K, Emi N, Tajima K. Hishida A, et al. Among authors: iwata h. J Natl Cancer Inst. 2002 Dec 4;94(23):1807-8. doi: 10.1093/jnci/94.23.1807. J Natl Cancer Inst. 2002. PMID: 12464653 No abstract available.

6

Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women.

Hishida A, Iwata H, Hamajima N, Matsuo K, Mizutani M, Iwase T, Miura S, Emi N, Hirose K, Tajima K. Hishida A, et al. Among authors: iwata h. Breast Cancer. 2003;10(1):63-9. doi: 10.1007/BF02967627. Breast Cancer. 2003. PMID: 12525765

7

Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer.

Yamada Y, Hamajima N, Kato T, Iwata H, Yamamura Y, Shinoda M, Suyama M, Mitsudomi T, Tajima K, Kusakabe S, Yoshida H, Banno Y, Akao Y, Tanaka M, Nozawa Y. Yamada Y, et al. Among authors: iwata h. J Mol Med (Berl). 2003 Feb;81(2):126-31. doi: 10.1007/s00109-002-0411-x. Epub 2003 Feb 11. J Mol Med (Berl). 2003. PMID: 12601529

8

Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.

Iwase H, Zhang Z, Omoto Y, Sugiura H, Yamashita H, Toyama T, Iwata H, Kobayashi S. Iwase H, et al. Among authors: iwata h. Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S34-8. doi: 10.1007/s00280-003-0592-1. Epub 2003 Jun 19. Cancer Chemother Pharmacol. 2003. PMID: 12819932

9

Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.

Huang XE, Hamajima N, Katsuda N, Matsuo K, Hirose K, Mizutani M, Iwata H, Miura S, Xiang J, Tokudome S, Tajima K. Huang XE, et al. Among authors: iwata h. Breast Cancer. 2003;10(4):307-11. doi: 10.1007/BF02967650. Breast Cancer. 2003. PMID: 14634508

10

The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.

Hirose K, Matsuo K, Toyama T, Iwata H, Hamajima N, Tajima K. Hirose K, et al. Among authors: iwata h. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1407-11. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,045 results

Search Page

Filters